CD19 and acute lymphoblastic leukemia: CD19‐specific CAR‐T cells also show limited therapeutic effects on other haematologic malignancies such as chronic lymphocytic leukaemia, lymphoma and multiple myeloma (NCT02135406); however, the response rates of these diseases are lower than that of B‐ALL.115, 116